Updated

Researchers report that JAK inhibitors, prescribed for rheumatoid arthritis and other inflammatory diseases, can weaken a key immune defense against influenza, COVID-19 and other infections. ScienceDaily reported that the drugs suppress genes that normally fight viruses. The findings suggest patients taking these medications may be more vulnerable to infection.